Protagonist Historical Balance Sheet
PTGX Stock | USD 40.58 0.67 1.62% |
Trend analysis of Protagonist Therapeutics balance sheet accounts such as Other Liabilities of 132.2 K, Net Tangible Assets of 141.3 M, Property Plant And Equipment Net of 3.4 M or Accounts Payable of 733.4 K provides information on Protagonist Therapeutics' total assets, liabilities, and equity, which is the actual value of Protagonist Therapeutics to its prevalent stockholders. By breaking down trends over time using Protagonist Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Protagonist Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Protagonist Therapeutics is a good buy for the upcoming year.
Protagonist Therapeutics Inventory |
|
Protagonist |
About Protagonist Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Protagonist Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Protagonist Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Protagonist Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Protagonist currently owns. An asset can also be divided into two categories, current and non-current.
Protagonist Therapeutics Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Protagonist Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Protagonist Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Protagonist Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Protagonist Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most accounts from Protagonist Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Protagonist Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagonist Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.At this time, Protagonist Therapeutics' Capital Surpluse is fairly stable compared to the past year. Short Term Debt is likely to rise to about 3.1 M in 2024, whereas Total Assets are likely to drop slightly above 204.1 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Cash | 123.7M | 125.7M | 186.7M | 196.1M | Accounts Payable | 1.6M | 3.6M | 772K | 733.4K |
Protagonist Therapeutics balance sheet Correlations
Click cells to compare fundamentals
Protagonist Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Protagonist Therapeutics balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 154.9M | 324.5M | 347.7M | 247.9M | 358.0M | 204.1M | |
Other Current Liab | (10.2M) | 19.8M | 36.4M | 22.5M | 18.2M | 12.7M | |
Total Current Liabilities | 35.4M | 40.2M | 44.0M | 31.2M | 21.3M | 27.7M | |
Total Stockholder Equity | (217.7M) | (283.8M) | (409.4M) | (536.8M) | 336.7M | 353.5M | |
Net Tangible Assets | 80.0M | 279.6M | 300.0M | 215.6M | 247.9M | 141.3M | |
Property Plant And Equipment Net | 7.7M | 6.4M | 6.7M | 4.6M | 2.1M | 3.4M | |
Net Debt | (16.0M) | (111.4M) | (117.8M) | (122.1M) | (185.6M) | (176.3M) | |
Retained Earnings | (217.7M) | (283.8M) | (409.4M) | (536.8M) | (615.7M) | (584.9M) | |
Accounts Payable | 2.8M | 3.1M | 1.6M | 3.6M | 772K | 733.4K | |
Cash | 33.0M | 117.4M | 123.7M | 125.7M | 186.7M | 196.1M | |
Non Current Assets Total | 9.6M | 8.9M | 7.0M | 10.6M | 2.4M | 2.3M | |
Other Assets | 450K | 1.1M | 1.9M | 225K | 258.8K | 245.8K | |
Cash And Short Term Investments | 133.0M | 307.8M | 326.9M | 237.4M | 341.6M | 191.4M | |
Net Receivables | 6.8M | 2.4M | 1.6M | 52K | 10.3M | 10.8M | |
Common Stock Shares Outstanding | 25.9M | 34.4M | 46.3M | 49.0M | 56.8M | 29.8M | |
Short Term Investments | 100.0M | 188.5M | 203.2M | 111.6M | 154.9M | 99.8M | |
Liabilities And Stockholders Equity | (142.7M) | (238.9M) | (361.7M) | 247.9M | 358.0M | 375.8M | |
Non Current Liabilities Total | 39.5M | 4.6M | 3.7M | 784.7M | 221K | 210.0K | |
Inventory | 4.8M | 4.0M | 8.5M | (94K) | (10.3M) | (9.8M) | |
Other Current Assets | 744K | 7.4M | 12.3M | 5.7M | 3.6M | 3.6M | |
Other Stockholder Equity | 221K | 563.4M | 709.7M | 752.7M | 952.5M | 1.0B | |
Total Liab | 75.0M | 44.9M | 47.7M | 784.7M | 21.3M | 20.2M | |
Property Plant And Equipment Gross | 7.7M | 6.4M | 11.0M | 9.9M | 8.4M | 5.1M | |
Total Current Assets | 145.3M | 315.6M | 340.7M | 237.4M | 355.6M | 196.9M | |
Accumulated Other Comprehensive Income | (221K) | 28K | (299K) | (359K) | (105K) | (110.3K) | |
Property Plant Equipment | 7.7M | 1.5M | 6.7M | 1.6M | 1.8M | 2.5M | |
Capital Surpluse | 297.8M | 563.4M | 709.7M | 752.7M | 865.6M | 908.9M | |
Retained Earnings Total Equity | (217.7M) | (283.8M) | (409.4M) | (536.8M) | (483.1M) | (458.9M) | |
Current Deferred Revenue | 41.5M | 14.5M | 1.6M | 69K | 3K | 2.9K | |
Net Invested Capital | 89.8M | 279.6M | 300.0M | 215.6M | 336.7M | 228.6M | |
Net Working Capital | 109.9M | 275.4M | 296.7M | 211.9M | 334.3M | 227.5M | |
Short Term Debt | 1.3M | 2.9M | 4.4M | 5.0M | 2.3M | 3.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Protagonist Stock Analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.